Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1b Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab for Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC)

The purpose of this study is to determine whether the combination of a neoantigen vaccine targeting the DNAJB1-PRKACA fusion kinase in combination with DRP-104…

Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07430202